ConductScience.org, home

Paper972697

Mechanisms of bone destruction in the development of skeletal metastases.

Galasko CS. Nature, 1976. Cited by 261 papers, by iCite.

Cite this record

ConductScience Library. Mechanisms of bone destruction in the development of skeletal metastases. Papers, record 972697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/972697

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanisms of bone destruction in the development of skeletal metastases.
PubMed
Journal
Nature
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
261
iCite
Relative citation ratio, by iCite
9.37
iCite
Revised in PubMed
2019-06-17
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Galasko CSC S

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone NeoplasmsMajor topic
Bone ResorptionMajor topic
OsteoclastsMajor topic
Animals
Cell Division
Humans
Neoplasm Metastasis
Neoplasms, Experimental
Rabbits

Source PubMed

Download CSV of topics

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 261 citations.

PMIDTitleJournalYearIn PapersSource
33900965Features of Spinal Metastases: A Retrospective View.Int J Spine Surg2021https://conductscience.org/library/papers/33900965PubMed
31578655Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond.Clin Exp Metastasis2020https://conductscience.org/library/papers/31578655PubMed
24573404Establishment of successively transplantable rabbit VX2 cancer cells that express enhanced green fluorescent protein.Med Mol Morphol2015https://conductscience.org/library/papers/24573404PubMed
24448976Nuclear factor-kappa B ligand and osteoprotegerin levels in serum and gingival crevicular fluid in patients with bone metastases treated with zoledronic acid.Med Oncol2014https://conductscience.org/library/papers/24448976PubMed
22312491Physiopathology of spine metastasis.Int J Surg Oncol2011https://conductscience.org/library/papers/22312491PubMed
19050684Molecular mechanisms of metastasis in prostate cancer.Asian J Androl2009https://conductscience.org/library/papers/19050684PubMed
18057140Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.Endocr Rev2008https://conductscience.org/library/papers/18057140PubMed
16641914Malignant melanoma and bone resorption.Br J Cancer2006https://conductscience.org/library/papers/16641914PubMed
16542503Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026].Breast Cancer Res2006https://conductscience.org/library/papers/16542503PubMed
15988801Efficacy of oral etidronate for skeletal diseases in Japan.Yonsei Med J2005https://conductscience.org/library/papers/15988801PubMed
12498385A murine model of bone marrow micrometastasis in breast cancer.Clin Exp Metastasis2002https://conductscience.org/library/papers/12498385PubMed
11091506Parathyroid Hormone-related Protein in Breast Cancer Tissues: Relationship between Primary and Metastatic Sites.Breast Cancer1994https://conductscience.org/library/papers/11091506PubMed
10998677Neurophysiology of Cancer Pain: From the Laboratory to the Clinic.Curr Rev Pain1999https://conductscience.org/library/papers/10998677PubMed
9152972Utility of bisphosphonates in treating bone metastases.Med Oncol1996https://conductscience.org/library/papers/9152972PubMed
8698861Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.J Clin Invest1996https://conductscience.org/library/papers/8698861PubMed
8375111Hypercalcemia in breast cancer.Clin Exp Metastasis1993https://conductscience.org/library/papers/8375111PubMed
8143097Hypercalcaemia: historical perspectives and present management.Support Care Cancer1993https://conductscience.org/library/papers/8143097PubMed
8003863The expression of parathyroid hormone-related protein in human breast cancer with skeletal metastases.Surg Today1994https://conductscience.org/library/papers/8003863PubMed
7773580The management of hypercalcemia of malignancy.Support Care Cancer1995https://conductscience.org/library/papers/7773580PubMed
7734300Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer.Br J Cancer1995https://conductscience.org/library/papers/7734300PubMed

See all 43 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/972697

GET https://conductscience.org/api/papers/v1/972697/cited_by?page=2